An owners corporation has won orders requiring builder Ceerose and developer Zone Q rectify some defects in a Sydney apartment building, but failed to win work orders in relation to others.
The purchaser of Frankston’s $115 million Peninsula Kingswood Country Golf Club has lost a summary dismissal bid, with the court calling out its “contrariness” as stymieing the case’s progress without real cause.
A bid for approval of a seniors living complex on Sydney’s northern beaches has stalled after a court found a commissioner ignored mandatory considerations on the mistaken understanding that they conflicted with other planning requirements.
An appeals court has confirmed that mining companies AngloGold and IGO Limited did not need to renegotiate native title approvals when they consolidated 31 existing mining leases into a single lease.
A superannuation fund has taken McCullough Robertson to court, arguing that its former solicitors failed to warn that a $33 million share sale agreement with Firecroft Technical Services could be jeopardised if a related Fair Work Commission approval was quashed.
A court has upheld the $63.8 million valuation of an inner-Sydney high-rise, rejecting Meriton’s argument that it should be reduced to $52 million because of its isolation from public transport.
Chase Builders can’t avoid completing fire safety rectification works at the Manhattan on the Park apartment complex in Canberra by citing a 10-year limitations period after running down the clock with litigation, a tribunal has said.
A Sydney builder has lost its challenge to a $453,000 judgment for a developer, with an appeals court finding the construction company claimed payment for a greater amount of work than was done on a project in Dural.
The tax commissioner is challenging last month’s loss in a $948 million capital gains dispute with Malaysia’s YTL Power.
German pharmaceutical company Heidelberg Pharma has filed a lawsuit against Australian drug maker Telix alleging breach of a licence agreement for its kidney cancer diagnostic drug Zircaix.